BIOMAT Database Logo BIOMAT Database Logo

The current status of the surgical and medical treatment of the Zollinger-Ellison syndrome. 1990

T J Howard, and E Passaro

UI MeSH Term Description Entries
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011899 Ranitidine A non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers. AH-19065,Biotidin,N (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine,Ranisen,Ranitidin,Ranitidine Hydrochloride,Sostril,Zantac,Zantic,AH 19065,AH19065,Hydrochloride, Ranitidine
D002927 Cimetidine A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output. Altramet,Biomet,Biomet400,Cimetidine HCl,Cimetidine Hydrochloride,Eureceptor,Histodil,N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine,SK&F-92334,SKF-92334,Tagamet,HCl, Cimetidine,Hydrochloride, Cimetidine,SK&F 92334,SK&F92334,SKF 92334,SKF92334
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000897 Anti-Ulcer Agents Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. Anti-Ulcer Drugs,Agents, Anti-Ulcer,Anti Ulcer Agents,Anti Ulcer Drugs,Drugs, Anti-Ulcer
D015043 Zollinger-Ellison Syndrome A syndrome that is characterized by the triad of severe PEPTIC ULCER, hypersecretion of GASTRIC ACID, and GASTRIN-producing tumors of the PANCREAS or other tissue (GASTRINOMA). This syndrome may be sporadic or be associated with MULTIPLE ENDOCRINE NEOPLASIA TYPE 1. Syndrome, Zollinger-Ellison,Zollinger Ellison Syndrome
D015738 Famotidine A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion. Famotidine Hydrochloride,MK-208,Pepcid,YM-11170,MK 208,MK208,YM 11170,YM11170

Related Publications

T J Howard, and E Passaro
[Current status of treatment in the Zollinger-Ellison syndrome].
February 1983, Medicina clinica,
T J Howard, and E Passaro
[Surgical treatment of Zollinger-Ellison syndrome].
February 1980, Khirurgiia,
T J Howard, and E Passaro
Surgical treatment of the Zollinger-Ellison syndrome.
January 1993, World journal of surgery,
T J Howard, and E Passaro
[Surgical treatment of the Zollinger-Ellison syndrome].
January 1967, Actualites hepato-gastro-enterologiques,
T J Howard, and E Passaro
Zollinger-Ellison syndrome (gastrinoma). Current diagnosis and treatment.
April 1987, The Surgical clinics of North America,
T J Howard, and E Passaro
[Zollinger-Ellison syndrome--status determination].
September 1986, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen,
T J Howard, and E Passaro
[Current approach in the treatment of Zollinger-Ellison syndrome].
March 1990, Minerva chirurgica,
T J Howard, and E Passaro
[Current trends in the treatment of Zollinger-Ellison syndrome].
August 1983, Polski tygodnik lekarski (Warsaw, Poland : 1960),
T J Howard, and E Passaro
The role of surgical treatment in Zollinger-Ellison syndrome.
January 1994, Surgery annual,
T J Howard, and E Passaro
Medical treatment of Zollinger-Ellison syndrome with ranitidine.
January 1983, International journal of tissue reactions,
Copied contents to your clipboard!